TGF-β1 treatment induced a more pronounced increase in COL15A1 and TNC mRNA levels in ASMCs from COPD smokers versus non-COPD smokers, which were blocked by JQ1 treatment. This evidence concerns the gene COL15A1 and chronic obstructive pulmonary disease.